Enter your login e-mail to the account
Search
- PROSTATE CANCER
MUDr. Peter Kertes, Milan Blaško, Marián Hladík, Ján Hoffmann
(9/2007, Topic ) - Prostate cancer
doc. MUDr. Jozef Marenčák, PhD.
(3/2010, Review articles )
- The complications of lung cancer diagnostic process
MUDr. Radka Cahajlová, MUDr. Marián Marták
(6/2014, Original articles & case reports ) - 13th Central European Lung Cancer Conference, Praha, 24. – 27. 6. 2012
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Events ) - TECHNOLOGY DEVELOPMENT IN RADIATION THERAPY (part 2)
MUDr. Pavol Dubinský
(1/2008, Review articles ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Cancer cachexia – benefits and risks of nutritional support in cancer cachexia in the light of evidence-based medicine
MUDr. Ján Rajec, PhD., doc. MUDr. Michal Mego, PhD., MUDr. Silvia Cingelová, PhD.
(3/2013, Review articles ) - 12th Central European Lung Cancer Conference
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Events ) - 10. stredoeurópska konferencia o rakovine pľúc
doc. MUDr. Peter Beržinec, CSc.
(2/2006, Events ) - Adjuvant therapy of colorectal cancer in elderly patients
doc. MUDr. Mária Wagnerová, CSc., doc. MUDr. Alexander Berč, CSc.
(4/2007, Review articles ) - Chromosomal rearrangements in lung adenocarcinoma – new treatment options
RNDr. Katarína Hlinková
(3/2014, Review articles ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Managed hypertensive crisis induced by bevacizumab in patient with metastatic lung adenocarcinoma
MUDr. Klaudia Grácová, MUDr. Lucia Doláková
(6/2015, Main topic ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Importance of immunohistochemistry and application of TTF-1 and napsin A in differential diagnosis of primary pulmonary adenocarcinomas and pulmonary metastases of extrapulmonary origins
MUDr. Adela Mikuľaková, MUDr. Zuzana Hríbiková
(2/2017, Review articles ) - Publikujeme v zahraničí
(6/2015, Information & comments ) - Effective treatment of lung adenocarcinoma with target therapy – case report
MUDr. Gabriela Chowaniecová
(5/2017, Original articles & case reports ) - Zaujímavosti z literatúry: Analýzy biomarkerov a definitívne výsledky celkového prežitia z randomizovanej, otvorenej, prvolíniovej štúdie gefitinib verzus karboplatina/paklitaxel u klinicky vybraných pacientov s pokročilým nemalobunkovým karcinómom pľúc v
Editor rubriky: doc. MUDr. Peter Beržinec, CSc.
(3/2011, Information & comments ) - Circulating tumor DNA in non-small cell lung cancer patients with epidermal growth factor receptor mutations
MUDr. Michal Urda, MUDr. Simona Laštíková, MUDr. Juraj Mazal, prof. MUDr. Eva Rozborilová, CSc.
(5/2020, Review articles ) - The characteristics of lung cancer in young adults
MUDr. Peter Kasan, MUDr. Mária Černá, CSc., MUDr. Radka Cahajlová, MUDr. Marián Marták, MUDr. Milada Veselá, MUDr. Lucia Denková, MUDr. Zuzana Šviheľová-Lišková
(3/2016, Original articles & case reports ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - The effectiveness of second-generation ALK-TKIs in advance non-small cell lung cancer
MUDr. Simona Laštíková, MUDr. Michal Urda, PhD., MUDr. Juraj Mazal, MUDr. Marek Lafférs
(6/2021, Case reports ) - Effectivity of reduced dose of afatinib in patient with metastatic del 19 adenocarcinoma
MUDr. Michal Urda, MUDr. Simona Laštíková, MUDr. Juraj Mazal
(3/2020, Case reports ) - Osteoblastic flare effect during targeted therapy in lung adenocarcinoma
MUDr. Gabriela Chowaniecová
(4/2013, Original articles & case reports ) - Increased production of HE4 by tumour tissues and its importance of measurement in patients with malignant tumours
MUDr. Jaroslav Weissensteiner, doc. Mgr. Eva Babušíková, PhD.
(1/2015, Review articles ) - Current indications for pemetrexed in the treatment of non-small cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2009, Review articles ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - Lung cancer molecular testing in Slovak Republic – view clinical practise
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan, MUDr. Andrea Cipková, MPH., MUDr. Mária Černá, CSc., MUDr. Róbert Godál, MUDr. Gabriela Chowaniecová, MUDr. Igor Andrašina, CSc.
(6/2015, Main topic ) - Rare lung cancers
doc. MUDr. Peter Beržinec, CSc.
(2/2013, Main topic ) - Správa z podujatia ASCO Chicago 2012
(3/2012, Events ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - THE ROLE AND THE PLACE OF PHOTODYNAMIC THERAPY IN ONCOLOGY
prof. MUDr.eter Mlkvý, CSc.
(5/2007, Review articles ) - 12 12TH TH WORLD CONFERENCE ON LUNG CANCER, WORLD CONFERENCE ON LUNG CANCER,
doc. MUDr. Peter Beržinec, CSc.
(5/2007, Events ) - CURRENT GLOBAL AND LOCAL KNOWLEDGE AND PROBLEMS OF EPIDEMIOLOGY OF MALIGNANT TUMORS
doc. MUDr. Ivan Pleško, DrSc.
(1/2006, Review articles ) - ESMO 2010 – kongres, ktorý prelomil rekordy
doc. MUDr. Peter Beržinec, CSc.
(6/2010, Events ) - Actual therapeutic strategy of patients with non small cell lung cancer with EML4-ALK rearrangement
MUDr. Juraj Mazal, MUDr. Michal Urda, RNDr. Anna Farkašová, PhD.
(1/2017, Review articles ) - Stereotactic body radiotherapy
doc. MUDr. Pavol Dubinský, PhD., MUDr. Martin Jasenčák
(2/2016, Main topic ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes )
- Immunohistochemical expression of smooth muscle actin in basal cell carcinoma of the skin
MUDr. Jana Doboszová, MUDr. Vladimír Bartoš, PhD.
(3/2014, Original articles & case reports )
- Microcirculation in intestinal mucosa and its conextion to IBD
MUDr. Petronela Bušíková, PhD., doc. MUDr. Ján Porubský, CSc.
(3-4/2012, Review articles )